Gonadotropin-releasing hormone antagonists: effects on the ovarian follicle and corpus luteum.
Hall
J E
JE
D002986:Clinical Trials as Topic; D003338:Corpus Luteum / Q000187:drug effects*; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D008183:Luteal Phase / Q000097:blood / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood; D008597:Menstrual Cycle / Q000097:blood / Q000187:drug effects* / Q000502:physiology; D006080:Ovarian Follicle / Q000187:drug effects*; D011374:Progesterone / Q000097:blood
C057805:LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone